| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 04/21/2004 | EP1409682A2 Prevention and treatment of hcv infection employing antibodies directed against conformational epitopes |
| 04/21/2004 | EP1409653A1 Viral mutants that selectively replicate in targeted human cancer cells |
| 04/21/2004 | EP1409551A2 Chimeric capsid proteins and uses thereof |
| 04/21/2004 | EP1409012A1 Methods of inducing a cytotoxic immune response and recombinant simian adenovirus compositions useful therein |
| 04/21/2004 | EP1408909A2 Improved conditionally replicating vectors for inhibiting viral infections |
| 04/21/2004 | CN1490053A Selection and production of inactivated vaccine Lu8 line of hepatitis A |
| 04/21/2004 | CN1146657C Construction and use of recombinant herpes simplex virus |
| 04/20/2004 | US6723551 Gene expression control; genetic engineering |
| 04/20/2004 | US6723532 Plasmid for use in gene therapy |
| 04/20/2004 | US6723325 Attenuated vaccinia viruses that can be used in vaccination methods against variola virus |
| 04/20/2004 | US6723324 Chicken anaemia viruses of low pathogenicity |
| 04/20/2004 | US6723316 Herpes simplex virus-1 Glycoprotein C mutants for treating unwanted hyperproliferative cell growth |
| 04/20/2004 | CA2248182C Porcine reproductive and respiratory syndrome vaccine |
| 04/15/2004 | WO2004031381A1 Peptide capable of binding to nanographite structures |
| 04/15/2004 | WO2004031225A1 Orthopoxvirus vectors, genes and products thereof |
| 04/15/2004 | WO2004031210A2 Optimized multi-epitope constructs and uses thereof |
| 04/15/2004 | WO2004030694A1 Bacteriophage-mediated immunisation against hepatitis |
| 04/15/2004 | WO2004000351A1 Packaged virus-like particles for use as adjuvants: method of preparation and use |
| 04/15/2004 | WO2003099859A3 Novel use of adenoviruses and nucleic acids coding therefor |
| 04/15/2004 | WO2003061555A3 West nile vaccine |
| 04/15/2004 | WO2003054212A8 A method and compositions for conferring viral immunity and reversing viral pathogenesis via strategic infection with a theravirus thereby providing genomic integration of genetically engineered, replication incompetent, integrating viral dna |
| 04/15/2004 | US20040073008 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 04/15/2004 | US20040072787 Cancer |
| 04/15/2004 | US20040072152 Screening blood and identifying immunologically active antigen of herpes simplex virus (HSV) which attacks skin; diagnosing viral infection; viricides |
| 04/15/2004 | US20040071709 Corona-virus-like particles comprising functionally deleted genomes |
| 04/15/2004 | US20040071661 Synthetic viruses and uses thereof |
| 04/15/2004 | DE29624488U1 Inactivating parvovirus in blood and blood prods. with type C UV light - and device for the process, is simple and rapid and retains functionality of proteins |
| 04/15/2004 | CA2500955A1 Optimized multi-epitope constructs and uses thereof |
| 04/15/2004 | CA2499871A1 Orthopoxvirus vectors, genes and products thereof |
| 04/14/2004 | EP1407033A1 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva) |
| 04/14/2004 | EP1407032A1 Anti-neoplastic viral agents |
| 04/14/2004 | EP1407008A2 Influenza vaccine composition |
| 04/14/2004 | EP1407007A1 Attenuated circovirus |
| 04/14/2004 | EP1407006A1 Method for the recovery and purification of poxviruses from infected cells |
| 04/14/2004 | EP1406666A2 Adenoviral vectors with cell type specificity for mesenchymal cells |
| 04/14/2004 | EP1406642A2 Methods of polyvalent bacteriophage preparation for the treatment of bacterial infections |
| 04/14/2004 | EP0870044B1 Regulated protein expression in stably transfected mammalian cells |
| 04/14/2004 | CN1489630A HIV-like particles and use thereof |
| 04/14/2004 | CN1488757A Human vasular endothelial growth factor recombinant adenovirus and preparing method use thereof |
| 04/14/2004 | CN1145639C Subunit respiratory syncytial virus vaccine preparation |
| 04/13/2004 | US6720175 Mediating receptor-activated or ion channel-mediated intracellular calcium mobilization or concentration. |
| 04/13/2004 | US6720166 Non-a, non-b, non-c, non-c, non-d, non-e hepatitis reagents and methods for their use |
| 04/13/2004 | US6719982 Transcriptional activation is prevented; nervous system disorders; gene therapy; genetic engineering and expression |
| 04/13/2004 | US6719981 Stable, attenuated rabies virus mutants and live vaccines thereof |
| 04/13/2004 | US6719979 Avian-paramyxovirus nucleotide sequences for use in the detection and treatment of avian viral diseases |
| 04/13/2004 | US6719978 Virus-like particles for the induction of autoantibodies |
| 04/08/2004 | WO2004028478A2 Functional mutations in respiratory syncytial virus |
| 04/08/2004 | WO2002053712A9 Avian hepatitis e virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis e |
| 04/08/2004 | US20040067586 Comprises viral nucleotide sequences coding protein for treatment of tumors; gene therapy |
| 04/08/2004 | US20040067486 Nucleic acid containing one or more adaptive mutations, and Hepatitis c Virus (HCV) replicon enhanced cells ( cells having an increased ability to maintain an HCV replicon) |
| 04/08/2004 | US20040067242 Multi-subtype FIV vaccines |
| 04/08/2004 | US20040067217 Chimeric cell-targeting pathogenic organism and method of therapeutic use |
| 04/08/2004 | DE19822115B4 Retrovirale Gentransfervektoren Retroviral gene transfer vectors |
| 04/08/2004 | CA2499042A1 Functional mutations in respiratory syncytial virus |
| 04/07/2004 | EP1404852A1 Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter |
| 04/07/2004 | EP1404842A2 Perv screening method and use thereof |
| 04/07/2004 | EP1404819A2 Synthetic viruses and uses thereof |
| 04/07/2004 | EP1404818A1 Production of infectious hepadnavirus particles containing foamy retrovirus envelope proteins and methods of using the same |
| 04/07/2004 | EP1404816A2 Novel human hepatoma lines, methods for obtaining same and uses thereof |
| 04/07/2004 | EP0817836B1 Cell line and process for replicating rabies viruses and their quantitative detection |
| 04/07/2004 | EP0559884B2 Viral recombinant vectors for expression in muscle cells |
| 04/07/2004 | CN1487953A Recepter in the EDb Fibronection domain |
| 04/06/2004 | US6716967 Purified monoclonal antibody or binding portion thereof that specifically binds to a rupestris stem pitting associated virus coat protein or coat protein polypeptide |
| 04/06/2004 | US6716431 Rotavirus nonstructural protein 4 in which histidine or asparagine at amino acid position 47 is mutagenized to aspartic acid to produce alternative form which has reduced toxicity, while retaining its antigenicity and immunogenicity |
| 04/01/2004 | WO2004027054A1 Thermostable rna ligase from thermus phage |
| 04/01/2004 | WO2004027053A1 Chicken astrovirus type 2 |
| 04/01/2004 | WO2004027048A2 High titer recombinant aav production |
| 04/01/2004 | WO2004027037A2 RECOVERY OF RECOMBINANT HUMAN PARAINFLUENZA VIRUS TYPE 2 (HPIV2) FROM cDNA AND USE OF RECOMBINANT HPIV2 IN IMMUNOGENIC COMPOSITIONS AND AS VECTORS TO ELICIT IMMUNE RESPONSES AGAINST PIV AND OTHER HUMAN PATHOGENS |
| 04/01/2004 | WO2004027028A2 Compositions, methods and kits for detection of an antigen on a cell and in a biological mixture |
| 04/01/2004 | WO2004009762A9 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof |
| 04/01/2004 | WO2004003153A8 Live replicating spumavirus vector |
| 04/01/2004 | WO2004001032A3 Stable adenoviral vectors and methods for propagation thereof |
| 04/01/2004 | WO2003093461A3 Genomic library of cyanophage s-2l and functional analysis |
| 04/01/2004 | US20040063652 Introducing multiple nucleic acid molecules simultaneously without deletereous effects; controlling level of expression |
| 04/01/2004 | US20040063203 Non-adenoviral gene product-based complementing cells for adenoviral vectors |
| 04/01/2004 | US20040063189 Bacteriophages that infect bacillus bacteria (anthrax) |
| 04/01/2004 | US20040063188 Kit for treating gastrointestinal tract |
| 04/01/2004 | US20040063140 Methods for diagnosis of cancer using erbB-3 |
| 04/01/2004 | US20040063095 gM-negative EHV-mutants |
| 04/01/2004 | US20040062775 Nucleotide sequences; veterinary medicine; vaccine |
| 04/01/2004 | US20040062756 Genetic engineering; hematopoietic or stem cells; binding lentivirus vector to cell surfaces |
| 04/01/2004 | US20040062752 Genetic engineered polynucleotide; antihemophilic factor; in situ administering to liver |
| 04/01/2004 | CA2499404A1 Recovery of recombinant human parainfluenza virus type 2 (hpiv2) from cdna and use of recombinant hpiv2 in immunogenic compositions and as vectors to elicit immune responses against piv and other human pathogens |
| 04/01/2004 | CA2499386A1 High titer recombinant aav production |
| 03/31/2004 | EP1403375A2 Recombinant live avian vaccin, using avian herpes virus as vector |
| 03/31/2004 | EP1402075A1 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses |
| 03/31/2004 | EP1402025A1 Chimaeric phages |
| 03/31/2004 | EP1402023A2 Method for generating replication defective viral vectors that are helper free |
| 03/31/2004 | EP1402019A1 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes |
| 03/31/2004 | EP1402009A1 Novel mixed lineage kinase (7) (mlk7) polypeptide, polynucleotides encoding the same, and methods of use thereof |
| 03/31/2004 | EP1401859A2 Chimeric flavivirus vectors |
| 03/31/2004 | EP1015560B1 Modified small rna viruses |
| 03/31/2004 | EP0742833B1 Recombinant baculovirus and use thereof in the production of monoclonal antibodies |
| 03/31/2004 | CN1486328A Method for surface display of proteins on genetic carriers |
| 03/31/2004 | CN1143892C Recombinant sendal virus |
| 03/30/2004 | US6713296 Due to a deletion of at least 10 amino acids, neurovirulence is attenuated as compared to a naturally occurring varicella-zoster virus |
| 03/30/2004 | US6713286 Purified fiv-141 virus; vaccines |
| 03/30/2004 | US6713070 Viral particles which are released after the infection with the human cytomegalovirus, and the use of said particles as a vaccine |
| 03/30/2004 | US6713066 Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2 |
| 03/30/2004 | US6713064 Immune enhancing agent for treating HIV infected humans |